Carregant...
Comparative performance of oral midazolam clearance and plasma 4β‐hydroxycholesterol to explain interindividual variability in tacrolimus clearance
AIMS: We compared the CYP3A4 metrics weight‐corrected midazolam apparent oral clearance (MDZ Cl/F/W) and plasma 4β‐hydroxycholesterol/cholesterol (4β‐OHC/C) as they relate to tacrolimus (TAC) Cl/F/W in renal transplant recipients. METHODS: For a cohort of 147 patients, 8 h area under the curve (AUC)...
Guardat en:
| Publicat a: | Br J Clin Pharmacol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5099550/ https://ncbi.nlm.nih.gov/pubmed/27501475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13083 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|